Identifier |
20200312_nanos_newtreatmentsno1_01-pdf |
Title |
New Paradigm for the Treatment of Thyroid Eye Disease (PDF) |
Creator |
Prem Subramanian, MD, PhD |
Subject |
Graves Disease; Intravenous Corticosteroid; Teprotumumab; Clinical Activity Scale Score |
Description |
Thyroid-related ophthalmopathy (TRO) or thyroid eye disease (TED) occurs in up to 50% of patients with systemic Graves hyperthyroidism as well as a smaller percentage of patients with other autoimmune thyroid disorders such as Hashimoto thyroiditis. Some of the underlying immunological mechanisms have been studied and elucidated, including stimulatory pathways that lead to orbital fibroblast proliferation, fat hypertrophy, and extraocular muscle changes. |
Date |
2020-03 |
Language |
eng |
Format |
application/pdf |
Source |
2020 North American Neuro-Ophthalmology Society Annual Meeting |
Relation is Part of |
NANOS Annual Meeting 2020: New Treatments in Neuro-Ophthalmology-2020 Trends |
Collection |
Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu |
Publisher |
Spencer S. Eccles Health Sciences Library, University of Utah |
Holding Institution |
North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416 |
Rights Management |
Copyright 2020. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
ARK |
ark:/87278/s64r34nn |
Context URL |
The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/ |
Contributor Primary |
Prem Subramanian, MD, PhD |
Setname |
ehsl_novel_nam |
ID |
1543347 |
Reference URL |
https://collections.lib.utah.edu/ark:/87278/s64r34nn |